4

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: August 16, 2013
Period of Report: August 14, 2013
Accession Number: 0001144204-13-046628

View Document ↗ View on SEC.gov ↗